Actividad in vitro del tedizolid y de antibióticos de comparación en aislamientos de Staphylococcus aureus resistentes a meticilina en infecciones de piel y tejidos blandos en siete hospitales de Colombia

Leal, Aura Lucía; Ovalle, María Victoria; Cortés, Jorge Alberto; Montañés, Anita María; De la Rosa, Zandra Rocío; Rodríguez, José Yesid; Gualtero, Sandra; Ariza, Beatriz; Sussman, Otto; Torres, María del Pilar.
Biomédica (Bogotá) ; 38(4): 507-513, oct.-dic. 2018. tab, graf
Artigo em Espanhol | LILACS | ID: biblio-983960

Documentos relacionados

  1. In vitro activity of tedizolid and other comparator drugs in methicillin-resistant Staphylococcus aureus isolates in skin and soft tissue infections in seven Colombian hospitals
  2. Simple and Efficient Synthesis of 3-Aryl-2-oxazolidinone Scaffolds Enabling Increased Potency toward Biofilms.
  3. Target Therapeutic Ranges of Anti-MRSA Drugs, Linezolid, Tedizolid and Daptomycin, and the Necessity of TDM.
  4. WCK 4034: A promising oxazolidinone for treating gram positive infections.
  5. Subtherapeutic linezolid concentrations in a patient with morbid obesity and methicillin-resistant Staphylococcus aureus pneumonia: case report and review of the literature.
  6. A Phase III multicentre, randomized, double-blind trial to evaluate the efficacy and safety of oral contezolid versus linezolid in adults with complicated skin and soft tissue infections.
  7. [Pharmacological action and clinical effect of tedizolid phosphate (SIVEXTRO<sup>®</sup> Tablets 200 mg, for iv infusion 200 mg), a novel oxazolidinone-class antibacterial drug].
  8. Comparing the pharmacokinetics and organ/tissue distribution of anti-methicillin-resistant <i>Staphylococcus aureus</i> agents using a rat model of sepsis.
  9. <i>In Vitro</i> Activity and Potency of the Novel Oxazolidinone Contezolid (MRX-I) Tested against Gram-Positive Clinical Isolates from the United States and Europe.
  10. Activity of Tedizolid and Comparator Agents Against Gram-positive Isolates Causing Skin and Skin Structure Infections in Pediatric Patients in United States Hospitals (2015-2019).